Cardiovascular Burden of the V142I Transthyretin Variant | G

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA

jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Boston , Massachusetts , Los Angeles , California , United Kingdom , Portugal , Lisbon , Lisboa , British , American , Bridgebio Pharma , Daiichi Sankyo , Boehringer Ingelheim Lilly , Sanofi Pasteur , Boehringer Ingelheim , Us Department Of Health , American Heart Association , Merck Sharp Dohme , Broad Institute Of Harvard , Foundation For Sarcoidosis Research , Blood Institute , Doris Duke Foundation , Human Services , Boston Scientific , Amgen , Women Health Initiative , American College Of Medical Genetics , British Heart Foundation , National Institutes Of Health , Mandel Foundation , National Institute On Aging , Eaton , Amgen Inc , National Center , Department Of Health , University Of California , Bristol Myers Squibb , Novartis , Pfizer , Translational Sciences , National Institute Of Neurological Disorders , Ionis Pharmaceuticals , Astrazeneca , Us Census Bureau American Community , Medtronic , Alnylam Pharmaceuticals , American Society Of Nuclear Cardiology , Meeting Of The European Society Cardiology , Diabetes Research Center , Translational Science Institute , Us Research Program , Glaxosmithkline , Affymetrix , Genetic Association Studies , Novo Nordisk , Institute For Translational Medicine , National Heart , University Of Pittsburgh , Duke Heart Center Leadership Council , American College , Medical Genetics , Communities Study , Atherosclerosis Risk , Ethnic Study , Multi Ethnic Study , Racial Differences , Stroke Study , Health Initiative , American Community Survey , Year Estimates , Cardiovascular Outcomes , Event Free Survival , Years Lost Based , Carrier Prevalence , Drs Selvaraj , Interest Disclosures , Translational Medicine , American Society , Nuclear Cardiology , Sarcoidosis Research , American Regent , Merck Sharp , National Institutes , Quantum Genomics , Cardiac Dimensions , National Institute , Neurological Disorders , Advancing Translational , Broad Institute , Affymetrix Genome Wide Human , Los Angeles Clinical , Heart Failure , European Society ,